Leukocyte count and the risk of adverse outcomes in patients with HFpEF.

Zhu, Zhaowei; Zhou, Shenghua

Zhu, Zhaowei; Zhou, Shenghua.

Affiliation

Zhu Z; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Zhou S; Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. zhoushenghua@csu.edu.cn.

BMC Cardiovasc Disord ; 21(1): 333, 2021 07 07.

Article in En | MEDLINE | ID: mdl-34233611

Subject(s)

Heart Failure/immunology; Inflammation/immunology; Leukocytes/immunology; Stroke Volume; Ventricular Function, Left; Aged; Female; Heart Failure/drug therapy; Heart Failure/mortality; Heart Failure/physiopathology; Hospitalization; Humans; Inflammation/mortality; Leukocyte Count; Male; Middle Aged; Mineralocorticoid Receptor Antagonists/therapeutic use; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

Key words

Adverse outcomes; HFpEF; Leukocyte

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke Volume / Ventricular Function, Left / Heart Failure / Inflammation / Leukocytes Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cardiovasc Disord Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2021 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google